Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
10.11
+0.69 (7.32%)
At close: May 20, 2026, 4:00 PM EDT
9.93
-0.18 (-1.78%)
After-hours: May 20, 2026, 7:23 PM EDT
Beta Bionics Revenue
Beta Bionics had revenue of $27.63M in the quarter ending March 31, 2026, with 56.62% growth. This brings the company's revenue in the last twelve months to $110.24M, up 57.87% year-over-year. In the year 2025, Beta Bionics had annual revenue of $100.25M with 53.94% growth.
Revenue (ttm)
$110.24M
Revenue Growth
+57.87%
P/S Ratio
4.09
Revenue / Employee
$260,610
Employees
423
Market Cap
450.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.25M | 35.13M | 53.94% |
| Dec 31, 2024 | 65.12M | 53.13M | 442.93% |
| Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
| Dec 31, 2022 | 179.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBBNX News
- 2 days ago - Beta Bionics price target lowered to $11 from $23 at BofA - TheFly
- 7 days ago - Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans - MarketBeat
- 8 days ago - Beta Bionics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Beta Bionics to Present at the Bank of America Securities Health Care Conference - GlobeNewsWire
- 4 weeks ago - Beta Bionics price target lowered to $20 from $22 at Stifel - TheFly
- 4 weeks ago - Beta Bionics price target lowered to $20 from $32 at Piper Sandler - TheFly
- 4 weeks ago - Beta Bionics reports Q1 EPS (49c), consensus (45c) - TheFly
- 4 weeks ago - Beta Bionics Earnings Call Transcript: Q1 2026 - Transcripts